| Scott R Springman, MD | |
|
5721 Summerhill Ct, Fitchburg, WI 53711-5883 | |
| (608) 283-8100 | |
| Not Available |
| Full Name | Scott R Springman |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Location | 5721 Summerhill Ct, Fitchburg, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316913825 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 22624 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Scott R Springman, MD 7974 Uw Health Ct, Middleton, WI 53562-5531 Ph: () - | Scott R Springman, MD 5721 Summerhill Ct, Fitchburg, WI 53711-5883 Ph: (608) 283-8100 |
News Archive
Neurological and infectious disease experts at Rush University Medical Center are testing a new drug therapy for the treatment of individuals with West Nile fever or suspected central nervous system infection due to the West Nile virus. Rush is the only site in the Midwest enrolling patients into the $50 million dollar, NIH-funded, Phase II clinical trial called PARADIGM.
Canada should prohibit disclosure of the sex of a fetus until after 30 weeks of pregnancy to combat female feticide which is practised by some ethnic groups in Canada and the United States, states an editorial in CMAJ.
Metabolex, Inc. announced today that they have entered into a global development and license agreement with Ortho-McNeil-Janssen Pharmaceuticals, Inc. to further develop and discover compounds for the treatment of type 2 diabetes and other disorders. Under the agreement, OMJPI will receive an exclusive worldwide license to develop, manufacture, and commercialize several Metabolex programs that are currently at the preclinical stage.
Providing a valuable incentive for U.S. investment in Australia, the Australian Government announced an agreement under which the Parliament will enact a AU$1.8 billion R&D tax credit that will deliver funding to innovative firms in industries including advanced manufacturing, information and communications technologies, and biotechnology.
Scientists now have a better understanding of a perplexing gene that is associated with susceptibility for a wide spectrum of severely debilitating mental illnesses. Two independent research studies published by Cell Press in the September 24th issue of the journal Neuron provide fascinating insight into the molecular mechanisms that link disrupted-in-schizophrenia 1 (DISC1) with the proper development and migration of neurons in the hippocampus, a brain area involved in learning and memory and associated with the pathology of schizophrenia.
› Verified 4 days ago
Michael Perouansky, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 5832 Woods Edge Rd, Fitchburg, WI 53711 Phone: 608-263-8100 | |
Mr. Brian Barreda, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 5755 Monticello Way, Fitchburg, WI 53719 Phone: 319-499-2485 |